Skip to main content
Top
Published in:

Open Access 01-05-2025 | COVID-19 | Original Communication

Long-term neuropsychological consequences of severe COVID-19 infection: the NEUROCOG-COVID study

Authors: Mylène Meyer, Thérèse Jonveaux, Claire Banasiak, Marine Bié, Leslie Cartz Piver, Anne Chatelain, Céline Dillier, Pascale Gerardin, Coraline Hingray, Christel Jacob, Laura Lavigne, Eloi Magnin, Salomé Puisieux, Louise Tyvaert, Gabriela Hossu, Lucie Hopes

Published in: Journal of Neurology | Issue 5/2025

Login to get access

Abstract

Background

Recent studies have confirmed the presence of cognitive disorders, which may be maintained over the long term and associated with psychological disorders following COVID-19 infection. The aim of our study was to characterize long-term cognitive and psychiatric disorders in patients younger than 65 years hospitalized for severe COVID-19 infection.

Methods

All patients who were hospitalized between October 2020 and July 2021 for severe COVID-19 infection with a cognitive complaint according to the QPC questionnaire were selected. They underwent a systematic neuropsychological evaluation assessing cognitive functions, psychological processes, and quality of life (QOL).

Results

The QPC was offered to 293 patients, 129 of whom had a cognitive complaint. A total of 74 (57% men) of these patients, aged approximately 55 years, had undergone a full neuropsychological evaluation 337.38 ± 25.11 days after hospital discharge. Seventy-three percent presented with cognitive disorders, including executive disorders (66%), memory disorders (31%), language disorders (19%), and other instrumental disorders (12%). Single-domain impairment was found in 54% of patients, with predominantly “dysexecutive syndrome” (83%) profile. There was no difference between the groups concerning psychological impairment. Patients with a “dysexecutive syndrome” profile reported poorer mental QOL than did the other patients (p < .05).

Conclusions

Cognitive disorders are common after severe COVID-19. The consideration of these factors is essential in the management of patients with long-term COVID-19, especially considering their impact on patients' QOL. Comprehensive neuropsychological assessment helps to identify the factors contributing to cognitive complaints to optimize multidisciplinary management, particularly when not related to cognitive disorders on testing.
Appendix
This content is only visible if you are logged in and have the appropriate permissions.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Long-term neuropsychological consequences of severe COVID-19 infection: the NEUROCOG-COVID study
Authors
Mylène Meyer
Thérèse Jonveaux
Claire Banasiak
Marine Bié
Leslie Cartz Piver
Anne Chatelain
Céline Dillier
Pascale Gerardin
Coraline Hingray
Christel Jacob
Laura Lavigne
Eloi Magnin
Salomé Puisieux
Louise Tyvaert
Gabriela Hossu
Lucie Hopes
Publication date
01-05-2025
Publisher
Springer Berlin Heidelberg
Keyword
COVID-19
Published in
Journal of Neurology / Issue 5/2025
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-025-13097-x

EAN 2025

Unlock your free and exclusive access to the latest news and expert interviews from the European Academy of Neurology's annual congress.

Read more

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest